|
|
???tair.name??? >
???browser.page.title.author???
|
"yeh yeh y m"???jsp.browse.items-by-author.description???
Showing items 1-10 of 10 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2023 |
HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study
|
Chen, P.-C.;Yeh, Yeh Y.-M.;Chu, Chu C.-T.;Su, P.-F.;Chiu, P.-H.;Lin, B.-W.;Chen, S.-H.;Lin, P.-C.;Lee, C.-T.;Chen, H.H.W.;Chen, Chen C.-C. |
| 國立成功大學 |
2023 |
Metabolomics analysis reveals changes related to pseudocyst formation induced by iron depletion in Trichomonas vaginalis
|
Cheng, W.-H.;Huang, P.-J.;Lee, C.-C.;Yeh, Yeh Y.-M.;Ong, S.-C.;Lin, R.;Ku, F.-M.;Chiu, Chiu C.-H.;Tang, P. |
| 國立成功大學 |
2022 |
A TSV-Structured Room Temperature p-Type TiO2 Nitric Oxide Gas Sensor
|
Yeh, Yeh Y.-M.;Chang, S.-J.;Wang, P.-H.;Hsueh, T.-J. |
| 國立成功大學 |
2022 |
CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer
|
Hsieh, C.-C.;Hsu, S.-H.;Lin, C.-Y.;Liaw, H.-J.;Li, T.-W.;Jiang, K.-Y.;Chiang, N.-J.;Chen, S.-H.;Lin, B.-W.;Chen, P.-C.;Chan, R.-H.;Lin, P.-C.;Yeh, Yeh Y.-M.;Shen, C.-H. |
| 國立成功大學 |
2022 |
PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer—Its Clinical and Biological Significance in Immune Microenvironment
|
Chung, B.-S.;Liao, I.-C.;Lin, P.-C.;Wu, S.-Y.;Kang, J.-W.;Lin, B.-W.;Chen, P.-C.;Chan, R.-H.;Lee, C.-T.;Shen, M.-R.;Chen, S.-H.;Yeh, Yeh Y.-M. |
| 國立成功大學 |
2022 |
A Prediction Model for Tumor Recurrence in Stage II–III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling
|
Chen, P.-C.;Yeh, Yeh Y.-M.;Lin, B.-W.;Chan, R.-H.;Su, P.-F.;Liu, Y.-C.;Lee, C.-T.;Chen, S.-H.;Lin, P.-C. |
| 國立成功大學 |
2022 |
A Room-Temperature TiO2-based Ammonia Gas Sensor with Three-Dimensional Through-Silicon-Via Structure
|
Yeh, Yeh Y.-M.;Chang, S.-J.;Wang, P.H.;Hsueh, T.-J. |
| 國立成功大學 |
2021 |
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers
|
Chang, K.-Y.;Chiang, N.-J.;Wu, S.-Y.;Yen, C.-J.;Chen, S.-H.;Yeh, Yeh Y.-M.;Li, C.-F.;Feng, X.;Wu, K.;Johnston, A.;Bomalaski, J.S.;Wu, B.-W.;Gao, J.;Subudhi, Subudhi S.K.;Kaseb, A.O.;Blando, J.M.;Yadav, S.S.;Szlosarek, P.W.;Chen, L.-T. |
| 國立成功大學 |
2020 |
Immune Checkpoint Inhibitors and Immune-Related Adverse Events in Patients with Advanced Melanoma: A Systematic Review and Network Meta-analysis
|
Chang, Chang C.-Y.;Park, H.;Malone, D.C.;Wang, C.-Y.;Wilson, D.L.;Yeh, Yeh Y.-M.;Van, Boemmel-Wegmann S.;Lo-Ciganic, W.-H. |
| 國立成功大學 |
2020 |
Neratinib plus capecitabine versus lapatinib plus capecitabine in HER2-positive metastatic breast cancer previously treated with ≥ 2 HER2-directed regimens: Phase III NALA trial
|
Saura, C.;Oliveira, M.;Feng, Y.-H.;Dai, M.-S.;Chen, S.-W.;Hurvitz, S.A.;Kim, S.-B.;Moy, B.;Delaloge, S.;Gradishar, W.;Masuda, N.;Palacova, M.;Trudeau, M.E.;Mattson, J.;Yap, Yap Y.S.;Hou, M.-F.;De, Laurentiis M.;Yeh, Yeh Y.-M.;Chang, H.-T.;Yau, T.;Wildiers, H.;Haley, B.;Fagnani, D.;Lu, Y.-S.;Crown, J.;Lin, J.;Takahashi, M.;Takano, Takano T.;Yamaguchi, M.;Fujii, T.;Yao, B.;Bebchuk, J.;Keyvanjah, Keyvanjah K.;Bryce, R.;Brufsky, A.;Investigators, NALA |
Showing items 1-10 of 10 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
